Related Experiment Videos
Second study shows that octreotide may prevent early rebleeding in cirrhosis
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Fetal treatment of sacrococcygeal teratoma: state of the art.
Frontiers in pediatrics·2025
Corrigendum: Gut and spleen anomalies associated with DYRK1A syndrome.
Frontiers in pediatrics·2024
Opioid prescribing after Joint Commission hospital accreditation inspections: quasi-experimental analysis.
BMJ (Clinical research ed.)·2026
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer control : journal of the Moffitt Cancer Center·2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal of comparative effectiveness research·2026